p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibitionKeelan Z. Guiley, Seth M. Rubin, Kevin Lou et al.|Science|2019Cited by 238
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic CancerVishnu Kumarasamy, Agnieszka K. Witkiewicz|Cancer Research|2024Cited by 45
Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberineVishnu Kumarasamy, Daekyu Sun|BMC Cancer|2015Cited by 36
Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycleVishnu Kumarasamy, Erik S. Knudsen|Nature Communications|2025Cited by 28
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivativeVishnu Kumarasamy, Daekyu Sun|International Journal of Oncology|2017Cited by 15